课题基金 / 基金详情

RESEARCH FOR THE PATHOMECHANISM, EPIDEMILOGY AND TREATMENTS FOR HAM AND HTLV-I RELATED DISORDERS.

RESEARCH FOR THE PATHOMECHANISM, EPIDEMILOGY AND TREATMENTS FOR HAM AND HTLV-I RELATED DISORDERS.
火腿和 HTLV-I 相关疾病的发病机制、流行病学和治疗研究。
批准号:
03454219
负责人:
OSAME Mitsuhiro
金额:
$3.97万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1991
资助国家:
日本
项目状态:
已结题
起止时间:
1991 至 1992

项目摘要

项目成果

OSAME Mitsuhiro的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This research provided several important results during these two years of investigation. In Kasari-town, which is a remote island in Kagoshima, we examined 384 inhabitants. Among them, 36(9.4%) had anti-HTLV-I antibodies in the serum. A longitudinal study of carriers will be done in the coming ten years. Lymphocyte separation was performed from 800 patients and family members who were admitted at Kagoshima University hospital. All of these samples were stored in liquid nitrogen.The clinical features and the laboratory data of 208 patients with HAM were entered in the computer for analysis. The results provided several important information regarding HAM. For instance, HAM may not sometimes have anti-HTLV-I antibodies in cerebrospinal fluid. The associated diseases in patients with HAM were also analyzed and their prevalence were calculated. The pathomechanisms of HTLV-I associated arthropathy, alveolitis, Shjogren syndrome, myositis. IgA nephropathy and pseudohypoparathyroidism were investigated and several important findings could be obtained. Five autopsied cases HAM were studied for neuropathological analysis. The specific importance of CD8lymphocytes was observed. Cytotoxic CD8 cells for the pX region were also found in the blood of patients. More than ten different therapeutic regimens were tried in HAM with very encouraging results.
期刊论文(55)
专著(0)
科研奖励(0)
会议论文
Takahashi K, Takezaki T, Oki T, et al: "Inhibitory effect of maternal antibody on mother-to-child transmission of human T-lymphotropic virus type I." Int. J. Cancer. 49. 673-677 (1991)
Takahashi K、Takezaki T、Oki T 等人:“母源抗体对 I 型人类 T 淋巴细胞病毒母婴传播的抑制作用。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Izumo S.,Ijichi T.,Higuchi I.et al.: "Neuropathology of HTLV-I-associated myelopathy. ーーA report of two autopsy casesーー" Acta Paediatrica Japonica. 34. 358-364 (1992)
Izumo S.、Ijichi T.、Higuchi I. 等人:“HTLV-I 相关脊髓病的神经病理学。-两个尸检病例的报告-”Acta Paediatrica Japonica 34. 358-364 (1992)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Higuchi I.,Nerenberg M,Yoshimine K.,et al.: "Failure to detect HTLV-1 by in situ hybridization in the biopsied muscles of viral carriers with polymyositis." Muscle & Nerve. 15. 43-47 (1992)
Higuchi I.、Nerenberg M、Yoshimine K. 等人:“通过原位杂交未能在患有多发性肌炎的病毒携带者的活检肌肉中检测到 HTLV-1。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ijichi T.,Higuchi I.,Fukunaga H.et al.: "Lymphocyte subsets in muscle biopsied of humn T-lymphotropic virus type I carriers with polymyositis." Int.Med.31. 973-977 (1992)
Ijichi T.、Higuchi I.、Fukunaga H.等人:“患有多发性肌炎的人类 T 淋巴细胞病毒 I 型携带者肌肉活检中的淋巴细胞亚群。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
44
    Exploitation of new therapies for HTLV-I-assotiated myelopathy
    • 批准号:
      14207031
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $23.71万
    • 财政年份:
      2002
    • 负责人:
      OSAME Mitsuhiro
    • 依托单位:
    HAMの臨床病態・発症機序の解明並びに新治療法の開発に関する研究
    • 批准号:
      11470146
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.15万
    • 财政年份:
      1999
    • 负责人:
      OSAME Mitsuhiro
    • 依托单位:
    Research on Pathomechanism and a novel treatment of HTLV-I-associated myelopathy (HAM)
    • 批准号:
      09470155
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.26万
    • 财政年份:
      1997
    • 负责人:
      OSAME Mitsuhiro
    • 依托单位:
    Pathology and Molecular Evolution of HTLV in Asia
    • 批准号:
      07042008
    • 项目类别:
      Grant-in-Aid for international Scientific Research
    • 资助金额:
      $10.24万
    • 财政年份:
      1995
    • 负责人:
      OSAME Mitsuhiro
    • 依托单位:
    国内基金
    海外基金
    KAT7介导组蛋白乳酸化修饰调控TSP1转录激活对衰老相关性房颤的影响及机制研究
    • 批准号:
      JCZRQNB202600709
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    血小板反应蛋白TSP1介导未分化甲状腺癌免疫治疗抵抗及机制研究
    • 批准号:
      QZSZ25H160006
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      徐通
    • 依托单位:
    TSP-1抑制剂通过抑制LTBP-1/TGF-β1信号通路延缓腹膜透析相关性腹膜纤维化的研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      郑欢欢
    • 依托单位:
    TSP1通过结合CD36增强肉豆蔻酸摄取上调COX6B2表达促进弥漫型胃癌腹膜转移的机制研究
    • 批准号:
      JCZRLH202500342
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
    • 依托单位: